Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nurix Therapeutics (NRIX) Tax Provisions (2019 - 2025)

Historic Tax Provisions for Nurix Therapeutics (NRIX) over the last 5 years, with Q2 2025 value amounting to $760000.0.

  • Nurix Therapeutics' Tax Provisions rose 74444.44% to $760000.0 in Q2 2025 from the same period last year, while for Nov 2025 it was $760000.0, marking a year-over-year increase of 18148.15%. This contributed to the annual value of $760000.0 for FY2025, which is 18148.15% up from last year.
  • Per Nurix Therapeutics' latest filing, its Tax Provisions stood at $760000.0 for Q2 2025, which was up 74444.44% from $8000.0 recorded in Q4 2024.
  • Over the past 5 years, Nurix Therapeutics' Tax Provisions peaked at $760000.0 during Q2 2025, and registered a low of -$123000.0 during Q3 2021.
  • For the 3-year period, Nurix Therapeutics' Tax Provisions averaged around $127555.6, with its median value being $82000.0 (2024).
  • In the last 5 years, Nurix Therapeutics' Tax Provisions soared by 3478.26% in 2021 and then skyrocketed by 74444.44% in 2025.
  • Nurix Therapeutics' Tax Provisions (Quarter) stood at $31000.0 in 2021, then tumbled by 74.19% to $8000.0 in 2024, then soared by 9400.0% to $760000.0 in 2025.
  • Its Tax Provisions stands at $760000.0 for Q2 2025, versus $8000.0 for Q4 2024 and $82000.0 for Q3 2024.